Symbol="ICPT"
AssetType="Common Stock"
Name="Intercept Pharmaceuticals Inc"
Description="Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company is headquartered in New York, New York."
CIK="1270073"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="18 DESBROSSES STREET, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="435213000"
EBITDA="-73080000"
PERatio="None"
PEGRatio="-0.69"
BookValue="1.612"
DividendPerShare="0"
DividendYield="0"
EPS="-4.65"
RevenuePerShareTTM="8.0"
ProfitMargin="0.703"
OperatingMarginTTM="-0.249"
ReturnOnAssetsTTM="-0.0911"
ReturnOnEquityTTM="0"
RevenueTTM="294522000"
GrossProfitTTM="284726000"
DilutedEPSTTM="-4.65"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.149"
AnalystTargetPrice="15.25"
TrailingPE="-"
ForwardPE="7.99"
PriceToSalesRatioTTM="1.6"
PriceToBookRatio="44.19"
EVToRevenue="1.185"
EVToEBITDA="-3.593"
Beta="1.258"
num_52WeekHigh="21.86"
num_52WeekLow="8.82"
num_50DayMovingAverage="11.77"
num_200DayMovingAverage="14.85"
SharesOutstanding="41687100"
DividendDate="None"
ExDividendDate="None"
symbol="ICPT"
open="10.79"
high="10.88"
low="10.38"
price="10.44"
volume="738495.00"
latest_trading_day="2023-07-21"
previous_close="10.76"
change="-0.32"
change_percent="-2.9740%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="75"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="25"
Volume_recent_avg="1167735"
Change_recent_avg="-0.07"
Delta_recent_avg="0.84"
Variance_recent_avg="0.42"
Change_ratio_recent_avg="-0.59"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="25"
Aroon_momentum_negative="75"
image_negative_thumbnail_id_1="1156"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0190.jpeg"
image_negative_thumbnail_id_2="500"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0105.jpeg"
image_neutral_thumbnail_id_1="560"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0039.jpeg"
image_neutral_thumbnail_id_2="572"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0027.jpeg"
image_positive_thumbnail_id_1="1166"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Negative_0187.jpeg"
image_positive_thumbnail_id_2="991"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0153.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
